breast cancer Archives - NFCR

breast cancer

Triple Negative Breast Cancer – What Every Patient Should Know

Nearly 15-20% of breast cancers are so-called “triple negative,” meaning such cancers have tested negative in pathology reports for estrogen receptors, progesterone receptors, and Her2/Neu.   The growth of these cancers are not fueled by estrogen and progesterone, as are most cancers, and therefore, do not respond to hormonal therapies such as…...

Read more

7 Ways to Reduce Your Breast Cancer Risk

Unfortunately, breast cancer stats are staggering. Although there's no sure way to prevent breast cancer, here are 7 steps to minimize your risk....

Read more

Attacking Metastatic Tumors in the Brain

Targeting HER3 could cripple metastatic cancers that have spread to the brain. (Bethesda, MD, June 5, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind…...

Read more

Garlic: It’s Good For You

Garlic has been used as both food and medicine for thousands of years. Today, it is used to help prevent heart disease, high cholesterol, high blood pressure and to boost the immune system. Research has shown that eating garlic regularly may also help protect against cancer.[i] What makes garlic such…...

Read more

Party4Life 2016 & the Lucy Fund

Ongoing fundraising efforts in honor of Lucy Stanovick seek to find a cure for metastatic cancer. To date, over $200,000 has been raised in Lucy’s name....

Read more

Research by NFCR Scientists Reveals New Insights into Treatment Resistance of Metastatic Breast Cancer

Oscillating expression of a key cancer gene may impact treatment approaches for patients NFCR-supported scientist Dr. Daniel Haber and his team at the Massachusetts General Hospital Cancer Center have identified a dynamic gene expression in metastatic breast cancer that may contribute to disease progression and resistance to treatment experienced by many…...

Read more

Mary-Claire King, @UW 2016 Szent-Györgyi Prize

WASHINGTON, DC. NATIONAL PRESS CLUB.  May 2, 2016 6pm The National Press Club was the setting for the award ceremony recognizing Mary-Claire King, Ph.D., University of Washington professor of medicine and genome sciences as the 2016 recipient of the Szent-Györgyi Prize for Progress in Cancer Research presented annually by The National Foundation…...

Read more

Breast Cancer Treatments in the News

New Treatments Could Shrink Breast Cancer in Just 11 Days For patients with HER2-positive breast cancer, a new combination therapy with two drugs could shrink or even eliminate their tumors in just 11 days. About 10% of breast cancers are HER2-positive, which is a subtype of breast cancer that is aggressive…...

Read more